跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Belcytere - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Belcytere
Approved
STANDARD
Belcytere
Biolyse Pharma Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4b19b88d762c093e
Company
Biolyse Pharma Corporation
Type
Standard
Approval Details
Approval Id
4b19b88d762c093e
Drug Approval Philippines Name
Belcytere
Product Name
Belcytere
Registration Number
DR-XY48246
Brand Name
Belcytere
Generic Name
Docetaxel
Dosage Form
Solution for Injection (IV Infusion)
Dosage Strength
20 mg/mL (80 mg/4mL) (160 mg/8 mL)
Manufacturer
Biolyse Pharma Corporation
Importer
Belcynor Pharmaceuticals, Inc.
Issuance Date
29 July 2022
Expiry Date
29 July 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4b19b88d762c093e
Type
Standard
Back to Philippines FDA Approvals